- Home
- ENVB vs HSCS Comparison
ENVB vs HSCS Comparison
Compare ENVB & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- HSCS
- Stock Information
- Founded
- ENVB 1994
- HSCS 2007
- Country
- ENVB United States
- HSCS United States
- Employees
- ENVB N/A
- HSCS N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- ENVB Health Care
- HSCS Health Care
- Exchange
- ENVB Nasdaq
- HSCS Nasdaq
- Market Cap
- ENVB 3.2M
- HSCS 3.7M
- IPO Year
- ENVB N/A
- HSCS 2022
- Fundamental
- Price
- ENVB $1.21
- HSCS $3.50
- Analyst Decision
- ENVB Strong Buy
- HSCS Strong Buy
- Analyst Count
- ENVB 1
- HSCS 2
- Target Price
- ENVB $10.00
- HSCS $13.00
- AVG Volume (30 Days)
- ENVB 419.0K
- HSCS 19.7K
- Earning Date
- ENVB 05-14-2025
- HSCS 07-28-2025
- Dividend Yield
- ENVB N/A
- HSCS N/A
- EPS Growth
- ENVB N/A
- HSCS N/A
- EPS
- ENVB N/A
- HSCS N/A
- Revenue
- ENVB N/A
- HSCS N/A
- Revenue This Year
- ENVB N/A
- HSCS N/A
- Revenue Next Year
- ENVB N/A
- HSCS N/A
- P/E Ratio
- ENVB N/A
- HSCS N/A
- Revenue Growth
- ENVB N/A
- HSCS 261.17
- 52 Week Low
- ENVB $1.01
- HSCS $2.36
- 52 Week High
- ENVB $11.97
- HSCS $7.57
- Technical
- Relative Strength Index (RSI)
- ENVB 38.00
- HSCS 48.30
- Support Level
- ENVB $1.11
- HSCS $3.71
- Resistance Level
- ENVB $1.31
- HSCS $4.54
- Average True Range (ATR)
- ENVB 0.11
- HSCS 0.38
- MACD
- ENVB 0.04
- HSCS -0.04
- Stochastic Oscillator
- ENVB 26.33
- HSCS 22.27
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.